Farnaz Alibabaei
Overview
Explore the profile of Farnaz Alibabaei including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
19
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tahmasebi H, Arjmand N, Monemi M, Babaeizad A, Alibabaei F, Alibabaei N, et al.
Biomolecules
. 2025 Jan;
15(1).
PMID: 39858487
The growing prevalence of antibiotic-resistant bacteria within the human microbiome has become a pressing global health crisis. While antibiotics have revolutionized medicine by significantly reducing mortality and enabling advanced medical...
2.
Rad H, Tahmasebi H, Javani S, Hemati M, Zakerhamidi D, Hosseini M, et al.
Biomedicines
. 2025 Jan;
12(12.
PMID: 39767682
The gut microbiota plays a crucial role in modulating anticancer immunity, significantly impacting the effectiveness of various cancer therapies, including immunotherapy, chemotherapy, and radiotherapy. Its impact on the development of...
3.
Eslami M, Alibabaei F, Babaeizad A, Banihashemian S, Mazandarani M, Hoseini A, et al.
Biomolecules
. 2024 Nov;
14(11).
PMID: 39595522
The gut microbiota is a complex ecosystem that influences digestion, immune response, metabolism, and has been linked to health and well-being. Choline is essential for neurotransmitters, lipid transport, cell-membrane signaling,...
4.
Yousefi B, Kashanipoor S, Mazaheri P, Alibabaei F, Babaeizad A, Asli S, et al.
Biomedicines
. 2024 Nov;
12(11).
PMID: 39595098
() has emerged as a prominent multidrug-resistant (MDR) pathogen, significantly complicating treatment strategies due to its formidable resistance mechanisms, particularly against carbapenems. Reduced membrane permeability, active antibiotic efflux, and enzymatic...
5.
Tahmasebi H, Babaeizad A, Mohammadlou M, Alibabaei F, Banihashemian S, Eslami M
Microb Pathog
. 2024 Sep;
196:106944.
PMID: 39284519
The review discusses the recurrence of Mycoplasma pneumoniae (M. pneumoniae), a bacterium causing atypical pneumonia, primarily affecting Europe and Asia due to climate change, immunity decline, antibiotic resistance, and genetic...
6.
Hemmati M, Kashanipoor S, Mazaheri P, Alibabaei F, Babaeizad A, Asli S, et al.
Life Sci
. 2023 Jul;
329:121947.
PMID: 37463653
Cardiovascular disease (CVD) remains the most common cause of death worldwide and has become a public health concern. The proven notable risk factors for CVD are atherosclerosis, hypertension, diabetes, dyslipidemia,...